Evidence map›Paper›PMID 36375044›Full record

ArticleBlood advances2023

Histone deacetylase-6 modulates the effects of 4°C platelets on vascular endothelial permeability.

Byron Miyazawa, Alpa Trivedi, Lindsay Vivona, Maximillian Lin, Daniel Potter, Alison Nair, Mark Barry, Andrew P Cap, Shibani Pati

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Byron MiyazawaDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
Alpa TrivediDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
Lindsay VivonaDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
Maximillian LinDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
Daniel PotterDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
Alison NairDepartment of Pediatrics, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-3455-723X
Mark BarryDepartment of Surgery, University of California, San Francisco, San Francisco, CA.ORCID 0000-0003-2353-3312
Andrew P CapUS Army Institute of Surgical Research, JBSA-Ft. Sam Houston, San Antonio, TX.
Shibani PatiDepartment of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
University of California, San Francisco · USUnited States Army Institute of Surgical Research · US

Funding

The Therapeutic Potential of Cold Stored Platelets in Regulating Vascular Instability in TraumaR01HL147880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PATI, SHIBANI · 2020 to 2023
$2.0M
NHLBI NIH HHS R01 HL147880
6 · The paper itself

Abstract

Platelets (PLTs) stored at 4°C exhibit equivalent or superior hemostatic function compared with 22°C PLTs, but have shorter circulation times and a decreased ability to modulate vascular permeability. These differences may be due to morphological changes and storage-induced activation. Using a proteomics-based approach, we found that 4°C-stored PLTs express decreased α-tubulin, a key PLT structural protein. PLT activation is characterized by α-tubulin deacetylation, which is regulated by histone deacetylase-6 (HDAC-6). We hypothesized that inhibition of HDAC-6 in stored PLTs will improve their ability to regulate vascular permeability through reduced activation and α-tubulin deacetylation. In an in vivo model of vascular permeability, treatment of 4°C PLTs with the HDAC-6 inhibitor tubacin enhanced the vasculoprotective properties of untreated 4°C PLTs. 4°C PLT circulation, however, was unchanged by tubacin treatment, suggesting that circulation time may not be a critical factor in determining the vasculoprotective effects of PLTs. Assessing the factor content of stored PLTs revealed that angiopoietin-1 (Ang-1) increased in 4°C PLTs over time, which was further enhanced by tubacin treatment. In addition, angiopoietin-2, an inducer of vascular leak and antagonist of Ang-1, inhibited PLT barrier protection, suggesting involvement of the Tie-2 pathway. This study demonstrates that HDAC-6 inhibition with tubacin attenuates the diminished vasculo-protective properties of 4°C PLTs, and these properties may be independent of PLT circulation time.

Indexed as

Blood PlateletsTubulinAnilidesHistone DeacetylasesHydroxamic AcidsPermeabilityTemperatureAnilidesHistone DeacetylasesHydroxamic AcidstubacinTubulin

Identifiers

PMID36375044
PMCPMC10090218
OpenAlexW4308963931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.